What is the incidence of reversible encephalopathy syndrome in patients taking ciclosporin?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18404372
Cited by: 0

Abstract

The incidence of reversible encephalopathy syndrome in patients taking cyclosporine is recognized in clinical studies, though specific rates vary. It is a documented risk factor, particularly noted in contexts like kidney transplantation, with small studies indicating up to 1.66% incidence in some settings.

Fields of Study & Subjects

Neurological Complications and Syndromes Infectious Encephalopathies and Encephalitis Intensive Care Unit Cognitive Disorders

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
28 January 2026